Clinical Trial Update: Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency [Phase 2]

View source ↗

Summary

Phase II study of CK-1827452 in heart failure was terminated with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• CK-1827452

Snippet

Sponsor: Cytokinetics | Conditions: Heart Failure | Phase 2 | Status: TERMINATED | Results posted: 2010-08-23